Overall, our data showed that hCG stimulates cell proliferation, allowing us to hypothesize that the propensity of breast cancer cells to express the hormone receptor LHR renders them highly sensitive to hCG treatment by increasing their proliferative capacity. This evidence concerns the gene CD44 and breast carcinoma.